Sun Pharma to Pay Pfizer $550 Million

India's biggest drugmaker Sun Pharma experiencing huge decline after settling patent litigation with Pfizer
June 13, 2013
Sun Pharmaceuticals Ltd. is India's largest drugmaker according to market value, but shares have declined almost 3 percent. This drop is a result of Sun Pharma's patent litigation settlement with Pfizer Inc. Sun Pharma was found to have sold Pfizer's heartburn drug Protonix without authorization and has agreed to pay $550 million as a result. Read the full story.
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates